Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › A549 host cells comprising a recombinant oncolytic adenovirus with modified E1A cancer-specific promoter

A549 host cells comprising a recombinant oncolytic adenovirus with modified E1A cancer-specific promoter

US Patent 12291726 · Granted May 6, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitr2025
Methods and compositions utilizing RRx-001 combination therapy for radioprotecti2025
Methods and compositions utilizing RRx-001 combination therapy for radioprotecti2025
Personalized cancer vaccines2025
Personalized cancer vaccines2025
Personalized cancer vaccines2025
Recombinant adenoviruses carrying transgenes2025
Recombinant adenoviruses carrying transgenes2025
Recombinant adenoviruses carrying transgenes2025
Tumor-selective E1a and E1b mutants2025
Medication infusion devices, systems, and methods2024
Immunomodulatory fusion proteins2024